110 related articles for article (PubMed ID: 18538177)
1. Vinflunine: discovery and synthesis of a novel microtubule inhibitor.
Fahy J; Hellier P; Breillout F; Bailly C
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S3-5. PubMed ID: 18538177
[No Abstract] [Full Text] [Related]
2. Synthesis and biological evaluation of C-12' substituted vinflunine derivatives.
Lei XS; Yu XD; Yin L; Liu ZH; Tang PC
Bioorg Med Chem Lett; 2008 Aug; 18(16):4602-5. PubMed ID: 18653334
[TBL] [Abstract][Full Text] [Related]
3. Exploring the mechanisms of action of the novel microtubule inhibitor vinflunine.
Jordan MA; Horwitz SB; Lobert S; Correia JJ
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S6-S12. PubMed ID: 18538179
[TBL] [Abstract][Full Text] [Related]
4. Vinflunine.
Shnyder SD
IDrugs; 2004 Sep; 7(9):851-9. PubMed ID: 15470603
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics, metabolites, and preclinical safety of vinflunine.
Lobert S; Puozzo C
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S28-33. PubMed ID: 18538176
[TBL] [Abstract][Full Text] [Related]
6. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.
Ngan VK; Bellman K; Panda D; Hill BT; Jordan MA; Wilson L
Cancer Res; 2000 Sep; 60(18):5045-51. PubMed ID: 11016627
[TBL] [Abstract][Full Text] [Related]
7. Introduction. The novel microtubule inhibitor vinflunine.
Horwitz SB
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S1-2. PubMed ID: 18538173
[No Abstract] [Full Text] [Related]
8. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
Makarov AA; Tsvetkov PO; Villard C; Esquieu D; Pourroy B; Fahy J; Braguer D; Peyrot V; Lafitte D
Biochemistry; 2007 Dec; 46(51):14899-906. PubMed ID: 18052208
[TBL] [Abstract][Full Text] [Related]
9. Potential mechanisms of resistance to microtubule inhibitors.
Kavallaris M; Annereau JP; Barret JM
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S22-7. PubMed ID: 18538175
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of fluorinated catharanthine analogues and investigation of their biomimetic coupling with vindoline.
Giovanelli E; Moisan L; Comesse S; Leroux S; Rousseau B; Hellier P; Nicolas M; Doris E
Org Biomol Chem; 2013 Sep; 11(35):5885-91. PubMed ID: 23903701
[TBL] [Abstract][Full Text] [Related]
11. New semisynthetic vinca alkaloids: chemical, biochemical and cellular studies.
Orosz F; Comin B; Raïs B; Puigjaner J; Kovács J; Tárkányi G; Acs T; Keve T; Cascante M; Ovádi J
Br J Cancer; 1999 Mar; 79(9-10):1356-65. PubMed ID: 10188876
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and SAR of vinca alkaloid analogues.
Voss ME; Ralph JM; Xie D; Manning DD; Chen X; Frank AJ; Leyhane AJ; Liu L; Stevens JM; Budde C; Surman MD; Friedrich T; Peace D; Scott IL; Wolf M; Johnson R
Bioorg Med Chem Lett; 2009 Feb; 19(4):1245-9. PubMed ID: 19147348
[TBL] [Abstract][Full Text] [Related]
13. Direct coupling of catharanthine and vindoline to provide vinblastine: total synthesis of (+)- and ent-(-)-vinblastine.
Ishikawa H; Colby DA; Boger DL
J Am Chem Soc; 2008 Jan; 130(2):420-1. PubMed ID: 18081297
[TBL] [Abstract][Full Text] [Related]
14. First de novo synthesis of the bisindole alkaloid vinblastine.
Schneider C
Angew Chem Int Ed Engl; 2002 Nov; 41(22):4217-9. PubMed ID: 12434344
[No Abstract] [Full Text] [Related]
15. Total synthesis of (+)-vinblastine: control of the stereochemistry at C18'.
Yokoshima S; Tokuyama H; Fukuyama T
Chem Rec; 2010 Apr; 10(2):101-18. PubMed ID: 20394103
[TBL] [Abstract][Full Text] [Related]
16. Clinical activity of vinflunine in transitional cell carcinoma of the urothelium and other solid tumors.
Bellmunt J; Delgado FM; George C
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S34-43. PubMed ID: 18538178
[TBL] [Abstract][Full Text] [Related]
17. The effect of vindoline C-16 substituents on the biomimetic coupling reaction: synthesis and cytotoxicity evaluation of the corresponding vinorelbine analogues.
Song W; Hu L; Meng Y; Ma L; Guo D; Liu X; Hu L
Bioorg Med Chem Lett; 2012 May; 22(10):3485-7. PubMed ID: 22525316
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of vinflunine: effector pathways and potential for synergies.
Braguer D; Barret JM; McDaid H; Kruczynski A
Semin Oncol; 2008 Jun; 35(3 Suppl 3):S13-21. PubMed ID: 18538174
[TBL] [Abstract][Full Text] [Related]
19. Syntheses of 5a'-homo-vinblastine and congeners designed to establish structural determinants for isolation of atropisomers.
Kuehne ME; Cowen SD; Xu F; Borman LS
J Org Chem; 2001 Aug; 66(16):5303-16. PubMed ID: 11485449
[TBL] [Abstract][Full Text] [Related]
20. Total synthesis and evaluation of vinblastine analogues containing systematic deep-seated modifications in the vindoline subunit ring system: core redesign.
Schleicher KD; Sasaki Y; Tam A; Kato D; Duncan KK; Boger DL
J Med Chem; 2013 Jan; 56(2):483-95. PubMed ID: 23252481
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]